Recombinant IL-4 treatment augments resistance to Borrelia burgdorferi infections in both normal susceptible and antibody-deficient susceptible mice

Journal of Immunology

Volumn 156, Issue 7, 1996, Pages 2488-2494

  Keane Myers, Andrea ^a   Maliszewski, Charles R ^b   Finkelman, Fred D ^c   Nickell, Steven P ^a,d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b AMGEN INC   (United States)

^c Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BORRELIA BURGDORFERI; CONTROLLED STUDY; DRUG EFFECT; HUMORAL IMMUNE DEFICIENCY; INFECTION; LYME DISEASE; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SPIROCHETE; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, BACTERIAL; B-LYMPHOCYTES; BORRELIA BURGDORFERI GROUP; FEMALE; HUMANS; INTERLEUKIN-4; LYME DISEASE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, SCID; RECOMBINANT PROTEINS; SPECIES SPECIFICITY; TIME FACTORS;

EID: 0029880763     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Steere, A. C., R. L. Grodzicki, A. N. Kornblatt, J. E. Craft, A. G. Barbour, W. Burgdorfer, G. Schmid, E. Johnson, and S. E. Malawista. 1983. The spirochetal etiology of Lyme disease. N. Engl. J. Med. 308:733.
2. Baranton, G., D. Postic, I. S. Girons, P. Boerlin, J.-C. Piffaretti, M. Assous, and P. A. D. Grimont. 1992. Delineation of Borrelia burgdorferi sensu stricto. Borrelia garinii sp. nov. and group VS461 associated with Lyme borreliosis. Int. J. Syst. Bacteriol. 42:378.
3. 1993. Lyme disease: United States. 1993. Morb. Mortal. Wkly. Rep. 43:564.
4. Barthold, S. W., D. H. Persing, A. L. Armstrong, and R. A. Peeples. 1991. Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. Am. J. Pathol. 139:263.
5. Fikrig, E., S. W. Barthold, F. S. Kantor, and R. A. Flavell. 1990. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science 250:553.
6. Johnson, R. C., C. Kodner, and M. Russell. 1986. Passive immunization of hamsters against experimental infection with Borrelia burgdorferi. Infect. Immun. 53:713.
7. Schaible, U. E., M. D. Kramer, K. Eichmann, M. Modolell, C. Museteanu, and M. M. Simon. 1990. Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficient (SCID) mice. Proc. Natl. Acad. Sci. USA 87: 3768.
8. Matyniak, J., and S. L. Reiner. 1995. T helper phenotype and genetic susceptibility in experimental Lyme disease. J. Exp. Med. 181:1251.
9. Keane-Myers, A., and S. P. Nickell. 1995. Role of IL-4 and IFN-γ in modulation of immunity to Borrelia burgdorferi infections in mice. J. Immunol. 155:2020.
10. Keane-Myers, A., and S. P. Nickell. 1995. T cell subset-dependent modulation of immunity to Borrelia burgdorferi infection in mice. J. Immunol. 154: 1770.
11. Barthold, S. W., C. L. Sidman, and A. L. Smith. 1992. Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am. J. Trop. Med. Hyg. 47:605.
12. Schaible, U. E., M. D. Kramer, U. B. Gobel, R. Wallich, and M. M. Simon. 1991. Experimental Borrelia burgdorferi infection in inbred mouse strains: antibody response and association of H-2 genes with resistance and susceptibility to development of arthritis. Eur. J. Immunol. 21:2307.
13. Yang, L., J. H. Weis, E. Eichwald, C. P. Kolbert, D. H. Persing, and J. J. Weis. 1994. Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues. Infect. Immun. 62:492.
14. Else, K. J., and R. K. Grencis. 1991. Cellular immune responses to the murine nematode parasite Trichuris muris. I. Differential cytokine production during acute or chronic infection. Immunology 72:508.
15. Urban, J. F., I. M. Katona, W. E. Paul, and F. D. Fintelman. 1991. Interleukin 4 is important in protective immunity to a gastrointestinal nematode infection in mice. Proc. Natl. Acad. Sci. USA 88:5513.
16. Urban, J. F., K. Madden, A. Svetc, A. Cheever, P. Trotta, W. Guase, and F. Finkelman. 1992. The importance of Th2 cytokines in protective immunity to nematodes. Immunol. Rev. 127:205.
17. Else, K. J., L. Hultner, and R. K. Grencis. 1992. Cellular immune responses to the nematode parasite Trichuris muris. II. Differential induction of Th subsets in resistant versus susceptible mice. Immunology 75:232.
18. Else, K. J., F. D. Finkelman, C. R. Maliszewski, and R. K. Grencis. 1994. Cytokine-mediated regulation of chronic intestinal helminth infection. J. Exp. Med. 179:347.
19. Finkelman, F. D., K. B. Madden, S. C. Morris, J. M. Holmes, N. Boiami, I. M. Katona, and C. R. Maliszewski. 1993. Anti-cytokine antibodies as carrier proteins: prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine complexes. J. Exp. Med. 179:347.
20. Hofmeister, E. K., and J. E. Childs. 1995. Analysis of Borrelia burgdorferi sequentially isolated from Peromiscus leucopus captured at a Lyme disease enzootic site. J. Infect. Dis. 172:462.
21. Kitamura, D., J. Roes, R. Kuhn, and K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ-chain gene. Nature 350:423.
22. Yang, L., Y. Ma, R. Schoenfeld, M. G. E. Eichwald, B. Araneo, and J. J. Weis. 1992. Evidence for B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice. Infect. Immun. 60:3033.
23. Barbour, A. 1984. Isolation and cultivation of Lyme disease spirochetes. Yale J. Biol. Med. 57:521.
24. Abrams, J. S., M. Roncarlo, H. Yssel, U. Andersson, G. J. Gleich, and J. E. Silver. 1992. Strategies of anti-cytokine monoclonal Ab development: immunoassays of IL-10 and IL-5 in clinical samples. Immunol. Rev. 127:5.
25. Schaible, U. E., R. Wallich, M. D. Kramer, G. Nerz, T. Stehle, C. Museteanu, and M. M. Simon. 1994. Protection against Borrelia burgdorferi infection in SCID mice is conferred by presensitized spleen cells and partially by B cells but not T cells alone. Int. Immunol. 6:671.
26. Snapper, C., and W. E. Paul. 1987. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944.
27. Snapper, C. M., and F. D. Finkelman. 1993. Immunoglobulin class switching. In Fundamental Immunology, 3rd Ed. W. E. Paul, ed. Raven Press, Ltd., New York, p. 837.
28. McCune, J. M., R. Namikawa, H. Kaneshima, L. D. Schultz, M. Leiberman, and I. L. Weissmann. 1988. The SCID-hu mouse model for the analysis of human hematolymphoid differentiation and function. Science 241:1632.
29. Coffman, R. L., B. W. Seymour, D. A. Lebman, D. D. Hiraki, J. A. Christenson, B. Schrader, H. M. Cherwinski, H. F. Savelkoul, F. D. Finkelman, M. W. Bond, and T. R. Mossman. 1988. The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol. Rev. 102:5.
30. Paul, W. E. 1992. The role of IL-4 in the regulation of B cell development, growth, and differentiation. In IL-4: Structure and Function. H. Spits, ed. CRC Press, Boca Raton, p. 57.
31. Roussel, F., E. Garcia, T. Defrance, C. Perrone, N. Vezzio, D. H. Hsu, R. Kastelain, K. W. Moore, and J. Banchareau. 1992. Interleukin-10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 89:1890.
32. Gajewsfci, T. F., J. Joyce, and F. W. Fitch. 1989. Antiproliferative effect of IFN-γ in immune regulation, III. Differential selection of Th1 and Th2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-γ. J. Immunol. 143:15.
33. Yoshida, A., Y. Koide, M. Uchijima, and T. O. Yoshida. 1994. IFN-γ induces IL-12 mRNA expression by a murine macrophage cell line, J774. Biochim. Biophys. Acta 198:857.
34. Heinzel, F. P., R. M. Rerko, F. Ahmed, and E. Pearlman. 1995. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J. Immunol. 155:730.
35. Manetti, R., P. Parronchi, M. G. Giudizi, M. P. Piccinn, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin 12 (IL-12)) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177:1199.
36. Kopf, M., G. LeGros, M. Bachmann, M. C. Lamers, H. Bluethmann, and G. Kohler. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362:245.
37. LeGros, G., S. Z. Ben-Sasson, R. Seder, F. D. Finkelman, and W. E. Paul. 1990. Generation of interleukin-4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J. Exp. Med. 172:921:.
38. Swain, S. L., A. D. Weinberg, M. English, and G. Huston. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145:3796.
39. Swain, S. L., L. M. Bradley, M. Croft, S. Tonkonogy, G. Atkins, A. D. Weinberg, D. D. Duncan, S. M. Hedrick, R. W. Dutton, and G. Huston. 1991. Helper T cell subsets: phenotype, function and the role of lymphokines in regulating their development. Immunol. Rev. 123:115.
40. Bosma, M. J. 1989. The scid mutation: occurrence and effect. Curr. Top. Microbiol. Immunol. 152:3.
41. Barthold, S. W., and L. K. Bockenstedt. 1993. Passive immunizing activity of sera from mice infected with Borrelia burgdorferi. Infect. Immun. 61:4696.
42. Fikrig, E., F. S. Kantor, S. W. Barthold, and R. A. Flavell. 1993. Protective immunity in Lyme borreliosis. Parasitol. Today 9:129.
43. Burd, P. R., H. W. Rogers, J. R. Gordon, C. A. Martin, S. Jayaraman, S. D. Wilson, A. M. Dvorak, S. J. Galli, and M. E. Dorf. 1989. Interleukin-3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J. Exp. Med. 170:245.
44. Plaut, M., J. H. Pierce, C. J. Watson, J. Hanley-Hyde, R. P. Nordan, and W. E. Paul. 1989. Mast cell lines produce lymphokines in response to cross linkage of Fc∈RI or to calcium ionophores. Nature 339:64.
45. Duray, P. H. 1989. Histopathology of clinical phases of human Lyme disease. Rheum. Dis. Clin. North Am. 15:691.